Placebo-controlled, double blind phase I single ascending dose trial of oral RO-6885247 (RG 7800) in healthy volunteers

Trial Profile

Placebo-controlled, double blind phase I single ascending dose trial of oral RO-6885247 (RG 7800) in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 04 May 2015

At a glance

  • Drugs RG 7800 (Primary)
  • Indications Spinal muscular atrophy
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 20 Apr 2015 According to a PTC Therapeutics, data from this trial will be presented at the 2015 American Academy of Neurology 67th Annual Meeting.
    • 04 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top